May 13, 2020 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces the addition of its current President, Andrew Stanton Alvis, to its growing Board of Directors and appointed Chairman of the Audit Committee. Mr. Alvis brings to Isodiol and its board of directors his extensive experience in…

April 3, 2020 – Vancouver, BC – Isodiol International Inc.(CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce a shareholder update. Dear Shareholders, The COVID-19 virus represents a new challenge for us all, and I want to formally update you on the situation as it pertains to Isodiol. We are…

April 1, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that it has reached an agreement with the holders of its outstanding $6,000,000 CAD aggregate principal amount of 8.00% secured convertible debentures (the “Holders”) that mature on November 29, 2020 (the…

Isodiol continues to broaden its distribution in the Food, Drug and Mass (FDM) retail channel. Oct 9, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces it has entered into a strategic relationship with Vitamin Shoppe, Inc. (NYSE: VSI) (“The Vitamin Shoppe”) for the launch…

Oct 3, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces that Pawceuticals, the CBD-based product line that naturally helps to restore a pet’s health and overall wellness, is now available to purchase across the United States. The Pawceuticals functional CBD pet products are designed…

Oct 1, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), announces the appointment of Andrew Alvis to serve as the Company’s President. Mr. Alvis has diverse experience in all aspects of leadership, operational efficiency and revenue growth. He possesses a background that spans across multiple…

Aug 30, 2019 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), announces that it has filed its audited consolidated financial statements and MD&A for the year ended June 30, 2019. Highlights of Fiscal Year 2019 include: The Company reports first quarter revenues of $4.2M, a significant reduction in operating expenses and…

Aug 12, 2019 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), provides an update on the delay on the filing of its audited annual financial statements, related management’s discussion and analysis and supporting officer certificates for the financial year ended March 31, 2019 (the “Filings”). The Company obtained a management cease…

July 30, 2019 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”), today announces a delay in the filing of its audited annual financial statements, related management’s discussion and analysis and supporting officer certificates for the financial year ended March 31, 2019 (the “Filings”). The Filings are required to be made…